SCHEMBL26028

SCHEMBL26028

C1=Cc2c3ccccc3cc3cccc1c23

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.47
ERBB2 P04626 1/20 0.47
FYN P06241 1/20 0.47
MAOA P21397 1/20 0.47
ACHE P22303 1/20 0.47
AHR P35869 1/20 0.47
CES1 P23141 1/20 0.41
ALDH1A1 P00352 7/20 0.38
HSD17B10 Q99714 6/20 0.38
HPGD P15428 4/20 0.38
HIF1A Q16665 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
P2RX4 Q99571 1/20 0.37
CYP1B1 Q16678 1/20 0.37
THRB P10828 1/20 0.37
HTR2A P28223 1/20 0.36
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29562021 1.00 CYP1A2 (0.47) CYP1A2ERBB2FYNMAOAACHE
Triphenylene SCHEMBL22493025 0.98 CYP1A2 (0.46) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4848697 0.86 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4850326 0.86 ALDH1A1 (0.52) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4852228 0.86 ALDH1A1 (0.49) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4853363 0.85 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4851840 0.85 CYP1A2 (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4853798 0.84 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17439394 0.83 CYP1A2 (0.43) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4853248 0.83 CYP1A2 (0.43) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8811 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12486454-B2 Zinc oxide-polycyclic aromatic hydrocarbon quantum dot capable of blue light emission and manufacturing method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-12-02 US claimed
US-20240366807-A1 RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN TRUSTEES OF TUFTS COLLEGE 2024-11-07 US claimed
EP-3653573-B1 SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, DEVICE PROVIDED WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORP (JP) 2024-08-14 EP claimed
US-11859242-B2 Template-directed nucleic acid targeting compounds CARNEGIE MELLON UNIVERSITY (US) 2024-01-02 US claimed
US-20230126798-A1 ZINC OXIDE-POLYCYCLIC AROMATIC HYDROCARBON QUANTUM DOT CAPABLE OF BLUE LIGHT EMISSION AND MANUFACTURING METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLGOY (KR) 2023-04-27 US claimed
CN-110785376-B Surface-modified inorganic nitride, composition, heat-conducting material and device with heat-conducting layer 富士胶片株式会社 2023-03-31 CN claimed
WO-2023023261-A1 RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN TRUSTEES OF TUFTS COLLEGE (US) 2023-02-23 WO claimed
CN-110226241-B Organic electroluminescent element and electronic device 出光兴产株式会社 2022-08-30 CN claimed
US-11370950-B2 Surface-modified inorganic nitride, composition, thermally conductive material, and device with thermally conductive layer FUJIFILM CORPORATION (JP) 2022-06-28 US claimed
US-10840456-B2 Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-11-17 US claimed
US-20040062927-A1 FLUORINATED DENDRONS AND SELF-ORGANIZING ULTRAHIGH DENSITY NANOCYLINDER COMPOSITIONS TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE 2004-04-01 US claimed
WO-2004027078-A2 FLUORINATED DENDRONS AND SELF-ORGANIZING ULTRAHIGH DENSITY NANOCYLINDER COMPOSITIONS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2004-04-01 WO claimed
US-6518314-B1 For treating cerebral amyloidosis; compounds that impede the transformation of dense microspheres (DMS) into amyloid NYMOX CORPORATION (CA) 2003-02-11 US claimed
EP-0983222-A1 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS NYMOX CORPORATION (CA) 2000-03-08 EP claimed
WO-1998052898-A9 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS NYMOX CORP (CA) 1999-04-01 WO claimed
WO-1998052898-B1 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS 1999-02-11 WO claimed
WO-1998052898-A1 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS NYMOX CORPORATION (CA) 1998-11-26 WO claimed
US-5403908-A Aryl styrene-based copolymer IDEMITSU KOSAN COMPANY, LIMITED (JP) 1995-04-04 US claimed
WO-1994013688-A1 DNA-ARMED RIBOZYMES AND MINIZYMES GENE SHEARS PTY. LIMITED (AU) 1994-06-23 WO claimed
US-4791232-A ANTITUMOR AGENTS BURROUGHS WELLCOME CO. (US) 1988-12-13 US claimed